New insider activity at GE Healthcare Technologies Inc ( (GEHC) ) has taken place on February 20, 2025.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
CAO George A. Newcomb recently executed a transaction involving the sale of 2,000 shares of GE Healthcare Technologies Inc stock, amounting to a total value of $185,080.
Recent Updates on GEHC stock
GE Healthcare Technologies Inc. has recently seen positive developments reflected in the latest earnings report and subsequent analyst actions. The company reported strong performance with a 2% increase in revenues and significant margin expansion, contributing to an adjusted EBIT margin of 18.7% and a robust growth in orders. However, challenges persist, particularly in the China market, which negatively impacted global sales growth. Despite these challenges, the company remains optimistic with strategic partnerships like the $1 billion Care Alliance with Sutter Health and new product launches, including the Flyrcado radiopharmaceutical. Analysts have responded positively to GE Healthcare’s performance, with price targets raised by Wells Fargo and Citi. The reasoning behind these changes includes the company’s strong EPS performance, significant operating margin improvements, and robust order growth, which outpaced expectations. The forward guidance for 2025 remains cautiously optimistic, focusing on innovation and strategic investments to sustain growth, despite anticipated challenges in China.
More about GE Healthcare Technologies Inc
YTD Price Performance: 18.58%
Average Trading Volume: 3,006,643
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $42.38B